CD133 Expression in Renal Cell Carcinoma (RCC) is Correlated with Nuclear Hypoxia-Inducing Factor 1α (Hif-1Α)

Chuanyang Sun,Hui Song,Hua Zhang,Chuansheng Hou,Tianhang Zhai,Lv Huang,Liang Zhang
DOI: https://doi.org/10.1007/s00432-012-1237-8
2012-01-01
Journal of Cancer Research and Clinical Oncology
Abstract:PURPOSE:In our previous study, we have found that the hypoxia-inducible factor 1α (HIF-1α) is upregulated in renal cell carcinoma (RCC) tissues compared with para-cancer normal tissues by 2-dimensional polyacrylamide gel electrophoresis. It was reported that hypoxic conditions were correlated with cancer stem cell generation and HIF-1α acted as a transcription regulator in nuclear HIF-1α expression. Therefore, in this study we investigate the relation between CD133 and nuclear HIF-1α expression levels in RCC tissues.METHODS:In this study 61 RCC tissues from the patients that treated with radical nephrectomy were collected. Then, we investigated the expression of CD133 and nuclear HIF-1α expression by immunohistochemistry. To verify the relation between CD133 and nuclear HIF-1α expression, we treated 786-O cells with cobalt chloride. The expression of CD133 on 786-O cells was analyzed by flowcytometry.RESULTS:The immunohistochemical study showed that CD133 was correlated with tumor stage and metastatic stage, whereas nuclear HIF-1α had no association with clinicopathological parameters. However, the expression of nuclear HIF-1α was correlated with CD133. The CD133 expression in 786-O cells was enhanced by cobalt chloride, which meant that CD133 expression was affected by hypoxia.CONCLUSIONS:Our study showed that in RCC, CD133 expression was strongly related to nuclear HIF-1α and the expression of CD133 might be upregulated under hypoxia environment.
What problem does this paper attempt to address?